ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 84 filers reported holding ATHIRA PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,000 | +300.0% | 1,930 | +589.3% | 0.00% | – |
| Q2 2023 | $1,000 | -80.0% | 280 | -85.3% | 0.00% | – |
| Q1 2023 | $5,000 | -70.6% | 1,903 | -63.8% | 0.00% | – |
| Q4 2022 | $17,000 | +70.0% | 5,257 | +48.5% | 0.00% | – |
| Q3 2022 | $10,000 | +400.0% | 3,540 | +621.0% | 0.00% | – |
| Q2 2022 | $2,000 | -98.6% | 491 | -95.4% | 0.00% | – |
| Q1 2022 | $143,000 | -56.9% | 10,617 | -58.3% | 0.00% | – |
| Q4 2021 | $332,000 | -65.1% | 25,462 | -74.9% | 0.00% | – |
| Q3 2021 | $952,000 | -39.9% | 101,513 | -34.4% | 0.00% | – |
| Q2 2021 | $1,585,000 | -34.7% | 154,739 | +17.2% | 0.00% | -100.0% |
| Q1 2021 | $2,429,000 | -8.8% | 131,995 | +69.8% | 0.00% | 0.0% |
| Q4 2020 | $2,663,000 | +424.2% | 77,747 | +182.7% | 0.00% | – |
| Q3 2020 | $508,000 | – | 27,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |